Horizon Discovery is a world-leader in the application of gene editing and is at the centre of innovation and drug discovery.



  • High science story with ongoing requirement for education of stakeholders


Our strategy

  • Work in partnership with management to develop an international IR and profile raising strategy to build knowledge and awareness
  • Simplify the story, outline achievable milestones and make the news impactful
  • Target international media to profile the Horizon investment case as the Company delivers on strategy and transitions to EBITDA positive in 2017


catalogue products and related research services in over 50 countries



  • Clearer announcements and media coverage, including tips by the Sunday Times’ Business Editor and the Financial Times, have had a positive impact on the share price with clear and well understood messages